Table 1 Demographic and baseline clinical characteristics
Total (n = 45) | Not severe MR (n = 33) | Severe MR (n = 12) | p value | |
|---|---|---|---|---|
Age at implantation [yrs] | 59.1 ± 10.7 | 58.2 ± 10.8 | 61.7 ± 10.5 | 0.35 |
Sex, male | 42 (93.3%) | 30 (93.3%) | 12 (100.0%) | 0.69 |
Valve surgery | ||||
AVR during LVAD | 5 (11.1%) | 3 (9.1%) | 2 (16.7%) | 0.86 |
TVR during LVAD | 1 (2.2%) | 1 (3.0%) | 0 (0%) | 1 |
Etiology | 1 | |||
NICM | 22 (48.9%) | 16 (48.5%) | 6 (50.0%) | |
ICM | 23 (51.1%) | 17 (51.5%) | 6 (50.0%) | |
Implant strategy | 0.25 | |||
BTT | 14 (31.1%) | 10 (30.3%) | 4 (33.3%) | |
DT | 14 (31.1%) | 8 (24.2%) | 6 (50.0%) | |
BTD | 14 (31.1%) | 12 (36.4%) | 2 (16.7%) | |
BTR | 3 (1.4%) | 3 (9.1%) | 0 (0%) | |
INTERMACS profile | 0.88 | |||
1 | 7 (15.6%) | 5 (15.2%) | 2 (16.7%) | |
2 | 11 (24.4%) | 8 (24.2%) | 3 (25.0%) | |
3 | 20 (44.4%) | 14 (42.4%) | 6 (50.0%) | |
4–7 | 7 (15.6%) | 6 (18.2%) | 1 (8.3%) | |
Pre-LVAD 6 MWT [m] | 301.8 ± 95.7 | 306.3 ± 85.0 | 293.3 ± 117.7 | 0.72 |